Results for:(84 found)
Aug 24, 2012 8:20AM on Top StocksBy Melly Alazraki

The ECB is considering yield band targets for a new bond-buying program. Orders for US durable goods jump, but the core number slides. Fed stimulus hopes fade. Autodesk plunges on disappointing results. Eli Lilly rallies on an Alzheimer's study.

Aug 16, 2012 12:47PM on Top StocksBy

The FDA is concerned about heart problems following issues related to rival Bristol-Myers' similar treatment for hepatitis C.

Aug 13, 2012 10:23AM on Top StocksBy Jim Cramer

While Romney's VP pick may be a good talking point this week, investors are still watching Europe.

Aug 3, 2012 9:58AM on Top StocksBy Jim Cramer

This lack of liquidity has led to a whole new set of rules.

Aug 2, 2012 3:56PM on Top StocksBy Jim J. Jubak

Shares of a 3% dividend yield, solid blue-chip drug company are valuable in shaky economic times.

Aug 2, 2012 12:37PM on Top StocksBy MSN Money Partner

Stocks slide following the European Central Bank president's press conference.

Jul 3, 2012 11:45AM on Top StocksBy The Fiscal Times

A slew of recent M&A activity may give hope to investment banks.

Jul 2, 2012 2:35PM on Top StocksBy Minyanville

The transaction also includes a $3.4 billion payment from AstraZeneca as the big drug companies try to replace lost sales from products with generic competition.



Copyright © 2014 Microsoft. All rights reserved.

Fundamental company data and historical chart data provided by Morningstar Inc. Real-time index quotes and delayed quotes supplied by Morningstar Inc. Quotes delayed by up to 15 minutes, except where indicated otherwise. Fund summary, fund performance and dividend data provided by Morningstar Inc. Analyst recommendations provided by Zacks Investment Research. StockScouter data provided by Verus Analytics. IPO data provided by Hoover's Inc. Index membership data provided by Morningstar Inc.


No more Dispatches; here's where to find market news

The Market Dispatches column has been discontinued. Here's where to find the latest stock and business news on MSN Money, and the latest from market writer Charley Blaine.